Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
Savara Stock Price, Quotes and Forecasts | NASDAQ:SVRA | Benzinga
Explore Savara stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SVRA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Savara (SVRA) stock?
You can purchase shares of Savara (NASDAQ:SVRA) through any online brokerage.
Who are Savara (SVRA) competitors?
Other companies in Savara’s space includes: Tectonic Therapeutic (NASDAQ:TECX), CytomX Therapeutics (NASDAQ:CTMX), Humacyte (NASDAQ:HUMA), Emergent BioSolutions (NYSE:EBS) and Ocugen (NASDAQ:OCGN).
What is the forecast, or price target, for Savara (SVRA) stock?
Savara has a consensus price target of $7.80.
What is the current price for Savara (SVRA)?
The stock price for Savara (NASDAQ: SVRA) is $2.08 last updated June 17, 2025 at 2:11 PM EDT.
Does Savara (SVRA) pay a dividend?
There are no upcoming dividends for Savara.
When is Savara (NASDAQ:SVRA) reporting earnings?
Savara’s Q2 earnings are confirmed for Monday, August 11, 2025.
Is Savara (SVRA) going to split?
There is no upcoming split for Savara.
What sector and industry does Savara (SVRA) operate in?
Savara is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
